Last Updated on December 31, 2023 by The Health Master
The US Food and Drug Administration (USFDA) recently approved expanded use of Yescarta, a cell therapy made by Gilead Sciences Inc’s Kite unit, as the first option after chemotherapy for adults with an advanced, aggressive form of blood cancer.
The one-time treatment was initially approved in 2017 for patients with large B-cell lymphoma who did not respond to at least two previous rounds of therapy.
Yescarta is part of a class of treatments known as CAR-Ts, which involve taking immune system blood cells from a patient, shipping them to a plant to be re-engineered to better fight certain cancers and then returning them to the patient.
Kite’s trial results showed that Yescarta improved the length of time patients stayed alive without serious complications by 60 per cent over chemotherapy and stem cell transplant in second-line large B-cell lymphoma.
The National Comprehensive Cancer Network, the most influential source of US oncology treatment guidelines, has already listed Yescarta in the first category of treatments for those patients.
The USFDA said the drug’s label warns of a serious complication associated with CAR-T therapy called cytokine release syndrome, which can cause a range of dangerous symptoms, including fever and neurological problems.
USFDA approves Ozempic 2 mg to treat Type-II Diabetes
USFDA gives nod to Lupin for Sildenafil for oral suspension
USFDA gives approval to Glenmark Pharma for Lacosamide Tablets
USFDA approves drug for treatment of Seizures associated with rare disease
USFDA approves new Bristol Myers cancer Immunotherapy
USFDA approves first generic of Symbicort to treat Asthma and COPD
Drug Recall: IDArubicin Hydrochloride Injection recalled due to this reason
USFDA gives 13 observations to Lupin
Govt further extends timeline to apply for slots under PLI scheme
CDSCO panel gives nod to Roche for Anticancer Drug Entrectinib Capsules
Nutraceuticals Regulations 2022 to encourage Pharma Industry
NPPA notifies revised ceiling price for 872 dosage forms formulations
Telangana to fill posts of 18 Drug Inspectors, 442 Pharmacists and 15 junior Analysts
NPPA updated price lists: Download
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
